vimarsana.com

Latest Breaking News On - Trevi therapeutics inc - Page 8 : vimarsana.com

Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update

Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023

Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Trevi Therapeutics to Participate in Upcoming August Events

/PRNewswire/ Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral.

Trevi Therapeutics, Inc (NASDAQ:TRVI) Sees Large Growth in Short Interest

Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,330,000 shares, a growth of 482.8% from the June 15th total of 228,200 shares. Based on an average daily volume of 381,600 shares, […]

Trevi Therapeutics to Participate in Upcoming July Investor Events

Trevi Therapeutics to Participate in Upcoming July Investor Events
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.